Heart Care Foundation
23
4
4
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
4.3%
1 terminated/withdrawn out of 23 trials
94.1%
+7.6% vs industry average
26%
6 trials in Phase 3/4
0%
0 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE
Role: lead
European Unified Registries for Heart Care Evaluation and Randomised Trials Italy
Role: lead
Hospitalizations During Pandemia in the Italian Coronary Care Unit Network
Role: lead
EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs
Role: lead
EARLY: Educational Intervention to Improve Patient Awareness on Early LDL-C Lowering in Secondary Prevention
Role: lead
Integrated Approach in Frail Older People with Atrial Fibrillation
Role: lead
BRING-UP 3 Heart Failure
Role: lead
BRING-UP Prevention
Role: lead
BLITZ Atrial Fibrillation
Role: lead
Left Ventricular DYsfunction in DiAbetes
Role: lead
Non-interventional Study on Patients With Atrial Fibrillation and Cancer
Role: lead
Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry
Role: lead
Contemporary Clinical Management Of Acute Pulmonary Embolism
Role: lead
Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure. AREA IN-CHF Study
Role: lead
STem cElls Mobilization in Acute Myocardial Infarction Outcome Trial
Role: lead
STable Coronary Artery Diseases RegisTry
Role: lead
EYESHOT (EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian Coronary Care Units)
Role: lead
Management of Antithrombotic TherApy in Patients With Atrial Fibrillation or DevelOping AtRial Fibrillation During Hospitalization for PCI
Role: lead
GlObal Secondary Prevention strategiEs to Limit Event Recurrence After Myocardial Infarction. GOSPEL Study
Role: lead
Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study
Role: lead